These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 25982135

  • 1. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi-institutional report from Pakistan.
    Fadoo Z, Nisar I, Yousuf F, Lakhani LS, Ashraf S, Imam U, Zaheer J, Naqvi A, Belgaumi A.
    Pediatr Blood Cancer; 2015 Oct; 62(10):1700-8. PubMed ID: 25982135
    [Abstract] [Full Text] [Related]

  • 2. Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA).
    Al-Mulla NA, Chandra P, Khattab M, Madanat F, Vossough P, Torfa E, Al-Lamki Z, Zain G, Muwakkit S, Mahmoud S, Al-Jassmi A, Tuncer M, Al-Mukharraq H, Barsaoui S, Arceci RJ, Howard SC, Kulozik AE, Ravindranath Y, Reaman GH, Farranoush M, AlNasser AA.
    Pediatr Blood Cancer; 2014 Aug; 61(8):1403-10. PubMed ID: 24648275
    [Abstract] [Full Text] [Related]

  • 3. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
    Navarrete M, Rossi E, Brivio E, Carrillo JM, Bonilla M, Vasquez R, Peña A, Fu L, Martinez R, Espinoza CM, Lacayo LF, Rodriguez H, Batista R, Barr R, Howard SC, Ribeiro RC, Masera G, Biondi A, Conter V, Valsecchi MG.
    Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [Abstract] [Full Text] [Related]

  • 5. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
    Gao C, Zhao XX, Li WJ, Cui L, Zhao W, Liu SG, Yue ZX, Jiao Y, Wu MY, Li ZG.
    Am J Hematol; 2012 Nov; 87(11):1022-7. PubMed ID: 22911440
    [Abstract] [Full Text] [Related]

  • 6. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram CR, Ludwig WD, Riehm H, Lampert F, Harbott J.
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcome of modified St Jude total therapy 13A for childhood acute lymphoblastic leukemia in the southeast region of Turkey.
    Koc A, Aycicek A, Ozdemir ZC, Soker M, Varma M.
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):36-41. PubMed ID: 23138117
    [Abstract] [Full Text] [Related]

  • 9. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM, Oren H, Baytan B, Bengoa SY, Evim MS, Gözmen S, Tüfekçi O, Karapınar TH, Irken G.
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [Abstract] [Full Text] [Related]

  • 10. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA.
    J Clin Oncol; 2008 Jun 20; 26(18):3046-50. PubMed ID: 18565891
    [Abstract] [Full Text] [Related]

  • 11. Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study.
    Yeoh AE, Ariffin H, Chai EL, Kwok CS, Chan YH, Ponnudurai K, Campana D, Tan PL, Chan MY, Kham SK, Chong LA, Tan AM, Lin HP, Quah TC.
    J Clin Oncol; 2012 Jul 01; 30(19):2384-92. PubMed ID: 22614971
    [Abstract] [Full Text] [Related]

  • 12. Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
    Lemez P, Attarbaschi A, Béné MC, Bertrand Y, Castoldi G, Forestier E, Garand R, Haas OA, Kagialis-Girard S, Ludwig WD, Matutes E, Mejstríková E, Pages MP, Pickl W, Porwit A, Orfao A, Schabath R, Starý J, Strobl H, Talmant P, van't Veer MB, Zemanová Z, European Group for the Immunological Characterization of Leukemias (EGIL).
    Eur J Haematol; 2010 Oct 01; 85(4):300-8. PubMed ID: 20561032
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M, Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG), Tokyo, Japan.
    Jpn J Clin Oncol; 2012 May 01; 42(5):394-404. PubMed ID: 22422899
    [Abstract] [Full Text] [Related]

  • 14. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
    Yang YL, Lin SR, Chen JS, Hsiao CC, Lin KH, Sheen JM, Cheng CN, Wu KH, Lin SW, Yu SL, Chen HY, Lu MY, Chang HH, Yen CT, Lin JF, Su YH, Li YP, Lin CY, Jou ST, Lin DT.
    J Pediatr Hematol Oncol; 2010 Nov 01; 32(8):e323-30. PubMed ID: 20930648
    [Abstract] [Full Text] [Related]

  • 15. Outcome of childhood acute lymphoblastic leukemia in Jordan.
    Halalsheh H, Abuirmeileh N, Rihani R, Bazzeh F, Zaru L, Madanat F.
    Pediatr Blood Cancer; 2011 Sep 01; 57(3):385-91. PubMed ID: 21360658
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ, Kamps WA, van den Berg H, van den Berg E, Bökkerink JP, Bruin MC, van den Heuvel-Eibrink MM, Korbijn CM, Korthof ET, van der Pal K, Stijnen T, van Weel Sipman MH, van Weerden JF, van Wering ER, van der Does-van den Berg A, Dutch Childhood Oncology Group.
    Lancet Oncol; 2009 Oct 01; 10(10):957-66. PubMed ID: 19747876
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
    Liang DC, Yang CP, Lin DT, Hung IJ, Lin KH, Chen JS, Hsiao CC, Chang TT, Peng CT, Lin MT, Chang TK, Jaing TH, Liu HC, Wang LY, Yeh TC, Jou ST, Lu MY, Cheng CN, Sheen JM, Chiou SS, Wu KH, Hung GY, Chen RL, Chen SH, Cheng SN, Chang YH, Chen BW, Ho WL, Wang JL, Lin ST, Hsieh YL, Wang SC, Chang HH, Yang YL, Huang FL, Chang CY, Chang WH, Lin KS.
    Leukemia; 2010 Feb 01; 24(2):397-405. PubMed ID: 20016538
    [Abstract] [Full Text] [Related]

  • 18. Response rate of Pakistani children with acute lymphoblastic leukaemia to Medical Research Council acute lymphoblastic leukaemia 97 chemotherapy protocol.
    Idris M, Farid J, Sarwar J, Ahmed S, Wiqar MA, Badsha S.
    J Ayub Med Coll Abbottabad; 2010 Feb 01; 22(3):8-11. PubMed ID: 22338406
    [Abstract] [Full Text] [Related]

  • 19. Pediatric Acute Lymphoblastic Leukemia: Clinical Characteristics, Treatment Outcomes, and Prognostic Factors: 10 Years' Experience From a Low- and Middle-Income Country.
    Ahmad I, Ghafoor T, Ullah A, Naz S, Tahir M, Ahmed S, Arshad A, Ali A, Khattack TA, Batool F.
    JCO Glob Oncol; 2023 Jun 01; 9():e2200288. PubMed ID: 37290024
    [Abstract] [Full Text] [Related]

  • 20. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
    Kanerva J, Saarinen-Pihkala UM, Niini T, Riikonen P, Möttönen M, Mäkipernaa A, Salmi TT, Vettenranta K, Knuutila S.
    Pediatr Blood Cancer; 2004 Jan 01; 42(1):30-5. PubMed ID: 14752791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.